Thereby, the breast tumor markers CEA and CA 15-3 showed good performances for differential diagnosis of breast cancer from healthy women and slightly lower sensitivities when patients with benign breast diseases were used as control groups. The gene discussed is CEACAM5; the disease is breast carcinoma.